{"name":"bioRASI, LLC","slug":"biorasi-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Test: Metronidazole Gel 1%","genericName":"Test: Metronidazole Gel 1%","slug":"test-metronidazole-gel-1","indication":"Treatment of rosacea","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Reference: Metronidazole Gel 1%","genericName":"Reference: Metronidazole Gel 1%","slug":"reference-metronidazole-gel-1","indication":"Bacterial vaginosis","status":"phase_3"}]}],"pipeline":[{"name":"Test: Metronidazole Gel 1%","genericName":"Test: Metronidazole Gel 1%","slug":"test-metronidazole-gel-1","phase":"phase_3","mechanism":"Metronidazole gel 1% works by killing bacteria and other microorganisms that cause infections.","indications":["Treatment of rosacea","Treatment of acne"],"catalyst":""},{"name":"Reference: Metronidazole Gel 1%","genericName":"Reference: Metronidazole Gel 1%","slug":"reference-metronidazole-gel-1","phase":"phase_3","mechanism":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and protozoal DNA by generating reactive free radicals, leading to cell death.","indications":["Bacterial vaginosis","Rosacea","Anaerobic bacterial infections (topical)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQczZ4M09mM0Z3ZDJlVzhKWkV1V2V0SmJUcEpQallPR0w3VG9vaTZOWDNXUERlVlBmQ0lpcHNmUGthWllMYnc0c241RUJMTGNEaXBwUFBhTkRjTlhhQ3R0dFlyUW1wWURfVmtQZDVvQlIxTm1MRlBhMVgzSWE3WDBqSzExWnlhanBNSi0tZUtyQkJrdVBRSGFPZUE0dw?oc=5","date":"2026-03-24","type":"trial","source":"openPR.com","summary":"Genital Herpes Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight - openPR.com","headline":"Genital Herpes Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNVmZsbEhBVXg0Q0VzOTNEQzFSdDN1dS1xZzh0cjlWOThZVUJMRDRtUTNtQnlDeGVoQ0o4YnpiQS1EcXBwVXZ2cmdFS3FIMmZLM1plQlVQTVBjd0pyWU1NZUxjcnVXdTA5X1NhQy02NEtMUThlYjhzdEZsdEFYaW8yNmd1cEdILWFF?oc=5","date":"2023-09-26","type":"pipeline","source":"Yahoo Finance","summary":"Global CRO Biorasi Welcomes Kristen K. Buck, MD as Scientific Medical Advisor - Yahoo Finance","headline":"Global CRO Biorasi Welcomes Kristen K. Buck, MD as Scientific Medical Advisor","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}